Awareness of the population regarding early detection of oncological diseases



მკერდის კიბო, კიბოს სკრინინგი, ონკოლოგიური დაავადებები


Today, malignant cancer is one of the most widespread diseases in the world, which causes the death of many people. In this regard, Georgia is not an exception and the disease is characterized by increasing trends here as well, which is accompanied by the rejuvenation of the disease. It is worth noting that the main reason for the high mortality caused by the disease is late diagnosis, which indicates low public awareness and the importance of early screening. That is why the aim of this work is to assess the level of awareness of the population about the importance of early diagnosis of oncological disease. In order to achieve this goal, the following tasks were developed: determining the main factors affecting the awareness of the population about the early diagnosis of oncological disease; determining the correlation of the awareness level of the population with the early diagnosis of oncological disease; Identifying the main barriers to non-screening. In order to answer the relevant tasks and achieve the goals, the quantitative research method was used, within the framework of which a one-time survey of the population was carried out; A specially prepared questionnaire was used as a research tool, which included information about the demographic data of the respondents, as well as about the early diagnosis and screening center of oncological diseases. As a result of the research, it was determined that the population has a high rate of satisfaction with the services of the screening center, however, the stereotypical ideas about oncological diseases that still exist in the population prevent the detection of the disease at an early, asymptomatic stage and a high rate of inclusion of the population in the screening program.


ავთვისებიანი ახალწარმონაქმნების გავრცელება საქართველოში, კიბოს პოპულაციური რეგისტრის 2015 წლის მონაცემები, დაავადებათა კონტროლისა და საზოგადოებრივი ჯანდაცვის ეროვნული ცენტრი

Austoker J, Bankhead C, Forbes LJ, Atkins L, Martin F, Robb K, Wardle J, Ramirez AJ. (2009). Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer. Dec 3;101 Suppl 2:S31-9.

Benjamin O. Anderson MD, Braun S, Lim S, Smith RA, Taplin S, Thomas DB, Hutchinson F. (2003). Early Detection of Breast Cancer in Countries with Limited Resources.

Bray F, Jemal A, Grey N, Ferlay J, Forman D. (2012). Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 13: 790-801.

Buist DS, Porter PL, Lehman C, et al. (2004). Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst.

Elmore JG, Armstrong K, Lehman CD, Fletcher SW. (2005). MSc Screening for Breast Cancer JAMA.

Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al, (2009). SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD: National Cancer Institute;

Humphrey LL, Helfand M, Chan BK, Woolf SH. (2002). Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 3;137(5 Part 1):347-60.

Jemal A, Center MM, Carol DeSantis, et al. (2010). Cancer Epidemiology, Biomarkers and Prevention

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. (2011). Global cancer statistics.


IARC (2002). Breast cancer screening, IARC handbooks for cancer prevention, International Agency for Research on Cancer.

IARC (2008). World cancer report 2008. Lyon, International Agency for Research on Cancer.

McTiernan A, Ulrich C, Slate S, Potter J. (1998). Physical activity and cancer etiology: associations and mechanisms. Cancer Causes Control

National Cancer Institute (2009). Surveillance Epidemiology and End Results (SEER) Stat Fact Sheets: Breast Cancer. Bethesda, MD: National Cancer Institute.

Nutbeam D. (2006). Department of Public Health and Community Medicine, A27, Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century University of Sydney, NSW, Australia

Ott JJ, Ullrich A, Miller AB. (2009). Noncommunicable Diseases and Mental Health Cluster, World Health Organisation, 20 Avenue Appia, 1211 Geneva 27, Switzerland; University of Toronto, Dalla Lana School of Public Health, Toronto, Canada.

Parkin DM, Almonte M, Bruni L, Clifford G, Curado MP, Pineros M. (2008). Burden and trends of type-specific human papillomavirus infections and related diseases in the latin america and Caribbean region. Vaccine.

Radimer KL, Ballard-Barbash R, Miller JS, et al. (2004). Weight change and the risk of late-onset breast cancer in the original Framingham cohort. Nutr Cancer

Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi (1996). Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet.

Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, et al. (2005). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. May;6(5):271-8.

Vainio H, Bianchini F. (2002). Weight Control and Physical Activity, vol. 6. Lyon, France: International Agency for Research Cancer Press.

WHO. (2010). Cancer - Screening and early detection

WHO. (2008). World Cancer Report 2008, IARC

WHO. (2013). Word Cancer day 2013.

World Health Organization (2013) comprehensive cervical cancer prevention and control: a healthier future for girls and women.



How to Cite

Osishvili, M. (2023). Awareness of the population regarding early detection of oncological diseases. Health Policy, Economics and Sociology, 7(2). Retrieved from